Ossendorp F - Search Results

1

Vaccine-induced effector-memory CD8+ T cell responses predict therapeutic efficacy against tumors.

van Duikeren S, Fransen MF, Redeker A, Wieles B, Platenburg G, Krebber WJ, Ossendorp F, Melief CJ, Arens R. van Duikeren S, et al. Among authors: ossendorp f. J Immunol. 2012 Oct 1;189(7):3397-403. doi: 10.4049/jimmunol.1201540. Epub 2012 Aug 22. J Immunol. 2012. PMID: 22914049

2

T cell depletion in transgenic mice carrying a mutant gene for TCR-beta.

Krimpenfort P, Ossendorp F, Borst J, Melief C, Berns A. Krimpenfort P, et al. Among authors: ossendorp f. Nature. 1989 Oct 26;341(6244):742-6. doi: 10.1038/341742a0. Nature. 1989. PMID: 2552327

3

Identification of an H-2 Kb-presented Moloney murine leukemia virus cytotoxic T-lymphocyte epitope that displays enhanced recognition in H-2 Db mutant bm13 mice.

Sijts AJ, De Bruijn ML, Ressing ME, Nieland JD, Mengedé EA, Boog CJ, Ossendorp F, Kast WM, Melief CJ. Sijts AJ, et al. Among authors: ossendorp f. J Virol. 1994 Sep;68(9):6038-46. doi: 10.1128/JVI.68.9.6038-6046.1994. J Virol. 1994. PMID: 7520098 Free PMC article.

4

Major differences in transporter associated with antigen presentation (TAP)-dependent translocation of MHC class I-presentable peptides and the effect of flanking sequences.

Neisig A, Roelse J, Sijts AJ, Ossendorp F, Feltkamp MC, Kast WM, Melief CJ, Neefjes JJ. Neisig A, et al. Among authors: ossendorp f. J Immunol. 1995 Feb 1;154(3):1273-9. J Immunol. 1995. PMID: 7822796

5

Immunodominant mink cell focus-inducing murine leukemia virus (MuLV)-encoded CTL epitope, identified by its MHC class I-binding motif, explains MuLV-type specificity of MCF-directed cytotoxic T lymphocytes.

Sijts AJ, Ossendorp F, Mengedé EA, van den Elsen PJ, Melief CJ. Sijts AJ, et al. Among authors: ossendorp f. J Immunol. 1994 Jan 1;152(1):106-16. J Immunol. 1994. PMID: 8254184

6

Competition inhibition of cytotoxic T-lymphocyte (CTL) lysis, a more sensitive method to identify candidate CTL epitopes than induction of antibody-detected MHC class I stabilization.

Feltkamp MC, Vierboom MP, Toes RE, Ossendorp F, ter Schegget J, Melief CJ, Kast WM. Feltkamp MC, et al. Among authors: ossendorp f. Immunol Lett. 1995 Jul-Aug;47(1-2):1-8. doi: 10.1016/0165-2478(95)00052-7. Immunol Lett. 1995. PMID: 8537084

7

A single residue exchange within a viral CTL epitope alters proteasome-mediated degradation resulting in lack of antigen presentation.

Ossendorp F, Eggers M, Neisig A, Ruppert T, Groettrup M, Sijts A, Mengedë E, Kloetzel PM, Neefjes J, Koszinowski U, Melief C. Ossendorp F, et al. Immunity. 1996 Aug;5(2):115-24. doi: 10.1016/s1074-7613(00)80488-4. Immunity. 1996. PMID: 8769475 Free article.

8

Immunotherapy of cancer by peptide-based vaccines for the induction of tumor-specific T cell immunity.

Ressing ME, Offringa R, Toes RE, Ossendorp F, de Jong JH, Brandt RM, Kast WM, Melief CJ. Ressing ME, et al. Among authors: ossendorp f. Immunotechnology. 1996 Nov;2(4):241-51. doi: 10.1016/s1380-2933(96)00057-7. Immunotechnology. 1996. PMID: 9373306 Review.

9

Specific T helper cell requirement for optimal induction of cytotoxic T lymphocytes against major histocompatibility complex class II negative tumors.

Ossendorp F, Mengedé E, Camps M, Filius R, Melief CJ. Ossendorp F, et al. J Exp Med. 1998 Mar 2;187(5):693-702. doi: 10.1084/jem.187.5.693. J Exp Med. 1998. PMID: 9480979 Free PMC article.

10

CD4 T cells and their role in antitumor immune responses.

Toes RE, Ossendorp F, Offringa R, Melief CJ. Toes RE, et al. Among authors: ossendorp f. J Exp Med. 1999 Mar 1;189(5):753-6. doi: 10.1084/jem.189.5.753. J Exp Med. 1999. PMID: 10049938 Free PMC article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

218 results

Search Page